For investors seeking momentum, Virtus Biotech Clinical Trials ETF BBC is probably on the radar now. The fund just hit a 52-week high and gained 2.2% from its 52-week low price of $51.24 per share.
Business News
Business News
For investors seeking momentum, Virtus Biotech Clinical Trials ETF BBC is probably on the radar now. The fund just hit a 52-week high and gained 2.2% from its 52-week low price of $51.24 per share.
